Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope
about
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infectionVirus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infectionTemporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndromeENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluidsHuman rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV InfectionBroad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaquesRole of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in MacaquesRelationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infectionCD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques.Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA allelesLimited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection.Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections.Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIVUnique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5.Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease.High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virusPredominant involvement of CD8+CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activityEfficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL.Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of diseaseEarly cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy.Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease.Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteersIL-15 increases the frequency of effector memory CD8+ T cells in rhesus monkeys immunized with HIV vaccine.Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.Virus escape from CTL recognitionHuman HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitisT cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus.Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memoryDeterminant of HIV-1 mutational escape from cytotoxic T lymphocytes.Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection.Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
P2860
Q24564779-D045AA64-1386-40CB-B36D-F636791F1564Q24645815-97BA1EDE-80BA-48A8-9638-2F6280730761Q24648628-57CCC247-EE63-4538-8842-753FC1094A43Q24682788-EDA026EB-1A62-41E8-B780-3CBCC3824F00Q32157115-65EE62B8-10D6-42D3-85F5-56291C65DEBBQ33620546-0030E4C5-9283-48E1-8CA7-7BB8BD217DCAQ33648533-ABEF7FC6-C088-4471-A90B-797BF4BC80BCQ33781916-6A915C0E-61BA-42F7-B1AA-D3F5DB822027Q33819493-B079394F-DB2C-41AB-A003-1093EEA9771CQ33828583-AE27AED6-FE3C-4D1D-8B5E-41EEB2B9EF2BQ33835440-E9BAF6E7-F2CB-439D-878B-166425E2D7EDQ33842286-FB98E7CA-FE1A-4A51-9620-60DFF3A60677Q33842771-69B60669-307B-4550-BD61-71A0006278E8Q33843340-EC9668C0-26C2-4381-89A9-3A0177C6C9A9Q34344082-F905E122-4F56-4F6C-91F2-6B91FE3DFBE2Q34514374-8F346280-457E-4634-8FDC-0A485EA144F5Q34996824-C9E389D4-54AE-4139-8642-83132EA4993CQ35127401-966ED630-898C-44E5-B77A-714AE1040232Q35188022-E8954DB9-BC53-487A-9057-7036EEAD67A6Q35372676-60712DED-7454-47E7-AB08-B0D3E75C500EQ35837479-F882842B-BBDD-45F9-82F5-BF3EE1613A8CQ35857819-0CF3C270-FEA8-4A2D-A99C-02D1ECC94394Q35867686-879F0FB9-F314-411C-8BCA-0047C8196E55Q35868324-11B2CB63-9853-4A53-AABD-2B5DAD1E9B9AQ35871440-8D2BDBEF-ECFB-4F6D-AE11-2681CE1BF6F5Q35873361-005C7CED-BEC2-411A-A6CA-3A5A407A50F4Q35875709-27D0E607-164B-49C0-9770-CB6498850C64Q35876809-B39EAE67-1A21-4CCB-9FA8-87562F340D09Q35887052-A7F5DBF6-7133-4CDF-BE63-9532AC817726Q35997008-7E5CA7D8-CF9D-4B43-AD96-6E0D029FAD50Q36036290-F738EA43-0292-4D4B-8676-F84F5A8F0B8AQ36315529-C16991B0-5883-496E-9C66-E1AA71636A3CQ36363636-F3B2FE43-2ECF-4757-892B-7841E209936CQ36364315-D8F3844A-5DB2-42DB-A5B3-935562C9CFBCQ36364632-F559A7D9-EBE1-4819-A24B-89424CBE8C7BQ36365148-D2994430-E0D1-492F-AFFD-42213375FFA1Q36367550-CF197727-8386-4363-A9A2-3CE8748C0168Q36370382-20369F15-5695-4360-B771-96B45B3D3A26Q36575290-5F120A22-6089-43AF-80EC-E0A4B91F2724Q36600351-BC777327-AE74-4349-9EDB-BC3FDF164A92
P2860
Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Characterization of human immu ...... nserved immunodominant epitope
@ast
Characterization of human immu ...... nserved immunodominant epitope
@en
type
label
Characterization of human immu ...... nserved immunodominant epitope
@ast
Characterization of human immu ...... nserved immunodominant epitope
@en
prefLabel
Characterization of human immu ...... nserved immunodominant epitope
@ast
Characterization of human immu ...... nserved immunodominant epitope
@en
P2093
P2860
P921
P356
P1476
Characterization of human immu ...... nserved immunodominant epitope
@en
P2093
P2860
P304
P356
10.1084/JEM.179.2.463
P407
P577
1994-02-01T00:00:00Z